Home
Frazier Life Sciences Public Fund reported a 6.7% stake in Xilio Therapeutics XLO · 4,676,472 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.7%
- Last report
- 9.9% · filed 25/08/14
- Shares held
- 4,676,472 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 25/12/31
- Filed
- 26/02/13
6.7% stake · −3.2pp from the last report
- Stake
- 6.7%
- Last report
- 9.9%
- Since last report
- −3.2pp
Xilio Therapeutics trades, last 26 weeks
What else happened in Xilio Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Frazier Life Sciences Public Fund's other 5% stake reports
- Frazier Life Sciences Public Fund
5% stakeAclaris Therapeutics
5% stakeAclaris Therapeutics
ACRS
5.4% stake
7,879,943 sh
5.4% stake
Filed 09/21
- Frazier Life Sciences Public Fund
5% stakeVor Biopharma
5% stakeVor Biopharma
VOR
4.2% stake
2,258,001 sh
4.2% stake
Filed 08/14
- Frazier Life Sciences Public Fund
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
5.5% stake
4,976,457 sh
5.5% stake
Filed 08/14
- Frazier Life Sciences Public Fund
5% stakeAttovia Therapeutics
5% stakeAttovia Therapeutics
ATTO
13.5% stake
6,154,213 sh
13.5% stake
Filed 08/11
- Frazier Life Sciences Public Fund
5% stakeMBX Biosciences
5% stakeMBX Biosciences
MBX
11.7% stake
5,243,421 sh
11.7% stake
Filed 08/10
